| Carolann Galban, MD | |
|
77 Danbury Rd, Ridgefield, CT 06877-4029 | |
| (203) 431-6342 | |
| Not Available |
| Full Name | Carolann Galban |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 33 Years |
| Location | 77 Danbury Rd, Ridgefield, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659309714 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 033136 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Danbury Hospital | Danbury, CT | Hospital |
| Bridgeport Hospital | Bridgeport, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| James K Ahern And Dr Carol A Galban Mds | 3476614199 | 2 |
News Archive
Scientists at the University of Virginia School of Medicine have developed a tool to monitor communications within the brain in a way never before possible, and it has already offered an explanation for why Alzheimer's drugs have limited effectiveness and why patients get much worse after going off of them.
South Africa's new five-year HIV/AIDS plan is an "unprecedented cooperation" between the government and civil society organizations in the country, Glenda Gray, executive director of the Perinatal Health Research Unit at the University of the Witwatersrand, and David Harrison, CEO of loveLife, write in a Sunday Independent opinion piece.
An editorial in the April 6 issue of the Journal of the American Medical Association cautions against estrogen-only hormone therapy in women who have had a hysterectomy because of longstanding evidence that it raises the risk of breast cancer.
A study conducted by researchers at Columbia University Medical Center found that older adults who used a hearing aid performed significantly better on cognitive tests than those who did not use a hearing aid, despite having poorer hearing. The study was published online in the American Journal of Geriatric Psychiatry.
Euthymics Bioscience, Inc. today will present Phase II clinical data demonstrating that its lead product candidate EB-1010, a next-generation antidepressant, is effective for treating major depressive disorder (MDD) based on multiple standard measures of outcome for depression. EB-1010 also improved measures of anhedonia, a hallmark symptom of MDD, which is characterized by the inability to experience pleasure.
› Verified 5 days ago
| Entity Name | James K Ahern And Dr Carol A Galban Mds |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942470810 PECOS PAC ID: 3476614199 Enrollment ID: O20081212000306 |
News Archive
Scientists at the University of Virginia School of Medicine have developed a tool to monitor communications within the brain in a way never before possible, and it has already offered an explanation for why Alzheimer's drugs have limited effectiveness and why patients get much worse after going off of them.
South Africa's new five-year HIV/AIDS plan is an "unprecedented cooperation" between the government and civil society organizations in the country, Glenda Gray, executive director of the Perinatal Health Research Unit at the University of the Witwatersrand, and David Harrison, CEO of loveLife, write in a Sunday Independent opinion piece.
An editorial in the April 6 issue of the Journal of the American Medical Association cautions against estrogen-only hormone therapy in women who have had a hysterectomy because of longstanding evidence that it raises the risk of breast cancer.
A study conducted by researchers at Columbia University Medical Center found that older adults who used a hearing aid performed significantly better on cognitive tests than those who did not use a hearing aid, despite having poorer hearing. The study was published online in the American Journal of Geriatric Psychiatry.
Euthymics Bioscience, Inc. today will present Phase II clinical data demonstrating that its lead product candidate EB-1010, a next-generation antidepressant, is effective for treating major depressive disorder (MDD) based on multiple standard measures of outcome for depression. EB-1010 also improved measures of anhedonia, a hallmark symptom of MDD, which is characterized by the inability to experience pleasure.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carolann Galban, MD 77 Danbury Rd, Ridgefield, CT 06877-4029 Ph: (203) 431-6342 | Carolann Galban, MD 77 Danbury Rd, Ridgefield, CT 06877-4029 Ph: (203) 431-6342 |
News Archive
Scientists at the University of Virginia School of Medicine have developed a tool to monitor communications within the brain in a way never before possible, and it has already offered an explanation for why Alzheimer's drugs have limited effectiveness and why patients get much worse after going off of them.
South Africa's new five-year HIV/AIDS plan is an "unprecedented cooperation" between the government and civil society organizations in the country, Glenda Gray, executive director of the Perinatal Health Research Unit at the University of the Witwatersrand, and David Harrison, CEO of loveLife, write in a Sunday Independent opinion piece.
An editorial in the April 6 issue of the Journal of the American Medical Association cautions against estrogen-only hormone therapy in women who have had a hysterectomy because of longstanding evidence that it raises the risk of breast cancer.
A study conducted by researchers at Columbia University Medical Center found that older adults who used a hearing aid performed significantly better on cognitive tests than those who did not use a hearing aid, despite having poorer hearing. The study was published online in the American Journal of Geriatric Psychiatry.
Euthymics Bioscience, Inc. today will present Phase II clinical data demonstrating that its lead product candidate EB-1010, a next-generation antidepressant, is effective for treating major depressive disorder (MDD) based on multiple standard measures of outcome for depression. EB-1010 also improved measures of anhedonia, a hallmark symptom of MDD, which is characterized by the inability to experience pleasure.
› Verified 5 days ago
Dr. Domenick John Masiello, DO Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 430 Old Sib Rd, Ridgefield, CT 06877 Phone: 203-826-3582 Fax: 855-798-2816 | |
James K Ahern, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 77 Danbury Rd, Ridgefield, CT 06877 Phone: 203-431-6342 Fax: 203-438-4548 | |
Dr. Thomas V Cigno, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 South St Ste 201, Ridgefield, CT 06877 Phone: 203-244-7848 Fax: 203-244-5111 | |
Wendy Maki, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 96 Danbury Rd, Ridgefield, CT 06877 Phone: 203-438-0874 Fax: 203-438-5986 | |
Justin Guy Ford, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 10 South St, Suite 101, Ridgefield, CT 06877 Phone: 203-431-4600 Fax: 203-431-4601 | |
Dr. Minelva Romelia Nanton Donato, M.D., PH.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 South St Ste 102, Ridgefield, CT 06877 Phone: 203-208-3230 Fax: 203-208-3231 |